Evidence map›Paper›PMID 25179879›Full record

ArticleAnatolian journal of cardiology2015

C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study.

Asghar Ghasemi, Hasan Aghajani, Soudabeh Fallah, Mehrdad Assadi, Morteza Seifi

Open access · bronzeAbstract read
In one paragraph

Article in Anatolian journal of cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Asghar GhasemiDepartment of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran-Iran. fallah.s@iums.ac.ie.
Hasan Aghajani
Soudabeh Fallah
Mehrdad Assadi
Morteza Seifi
Tehran University of Medical Sciences · IRIran University of Medical Sciences · IRUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIt is suggested that C771G (His241Gln) polymorphism of MLXIPL gene might be a genetic risk factor for coronary artery disease (CAD); therefore, the aim of the present study was to investigate the association between C771G polymorphism of MLXIPL gene and the pathogenesis of CAD in Iranian patients with coronary artery stenosis and control subjects.

methodsTwo hundred and five patients with coronary artery stenosis and 195 healthy control subjects were included in this study. MLXIPL genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism (RFLP).

resultsThere was an association between the MLXIPL polymorphism and quantitative lipid traits in patient group. Distribution of the CC genotype of MLXIPL was more frequent in patients, (χ2=5.13; p<0.005) and after adjustment for classical CAD risk factors, the MLXIPL CC genotype was independently associated with CAD (OR=1.98, 95% CI, 1.12-4.11; p=0.02). Distribution of MLXIPL genotypes were significantly different as compared with the severity of stenosis (χ2=6.34; p<0.05).

conclusionThese results suggest that C771G polymorphism of MLXIPL gene is associated with stenosis and its severity.

Indexed as

Genetic Predisposition to DiseaseBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCase-Control StudiesCoronary Artery DiseaseCoronary StenosisFemaleHumansIranMaleMiddle AgedPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthRisk FactorsWhite PeopleBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMLXIPL protein, human

Identifiers

PMID25179879
PMCPMC5336913
OpenAlexW2331437175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.